These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28709825)

  • 1. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.
    Chitadze G; Oberg HH; Wesch D; Kabelitz D
    Trends Immunol; 2017 Sep; 38(9):668-678. PubMed ID: 28709825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. γδ T cell-based anticancer immunotherapy: progress and possibilities.
    Meraviglia S; Lo Presti E; Dieli F; Stassi G
    Immunotherapy; 2015; 7(9):949-51. PubMed ID: 26569071
    [No Abstract]   [Full Text] [Related]  

  • 3. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the power of Vδ2 cells in cancer immunotherapy.
    Fowler DW; Bodman-Smith MD
    Clin Exp Immunol; 2015 Apr; 180(1):1-10. PubMed ID: 25469879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
    Paul S; Lal G
    Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy.
    Legut M; Cole DK; Sewell AK
    Cell Mol Immunol; 2015 Nov; 12(6):656-68. PubMed ID: 25864915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
    Miyashita M; Shimizu T; Ashihara E; Ukimura O
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
    Liu Z; Guo B; Lopez RD
    J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γδ cells and tumor microenvironment: A helpful or a dangerous liason?
    Lo Presti E; Di Mitri R; Pizzolato G; Mocciaro F; Dieli F; Meraviglia S
    J Leukoc Biol; 2018 Mar; 103(3):485-492. PubMed ID: 29345336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing γδ T cells in anticancer immunotherapy.
    Hannani D; Ma Y; Yamazaki T; Déchanet-Merville J; Kroemer G; Zitvogel L
    Trends Immunol; 2012 May; 33(5):199-206. PubMed ID: 22364810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
    Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
    Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γδ T cells in cancer.
    Silva-Santos B; Serre K; Norell H
    Nat Rev Immunol; 2015 Nov; 15(11):683-91. PubMed ID: 26449179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells.
    Xu J; Yu Y; Zhang Y; Dai H; Yang Q; Wang B; Ma Q; Chen Y; Xu F; Shi X; Liu Z; Wang C
    Nat Nanotechnol; 2024 Oct; 19(10):1569-1578. PubMed ID: 39054386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for immunotherapy of acute myeloid leukemia using γδ T cells.
    Halim L; Parente-Pereira AC; Maher J
    Immunotherapy; 2017 Jan; 9(2):111-114. PubMed ID: 28128710
    [No Abstract]   [Full Text] [Related]  

  • 19. γδ T cells and the PD-1/PD-L1 axis: a love-hate relationship in the tumor microenvironment.
    Liu J; Wu M; Yang Y; Wang Z; He S; Tian X; Wang H
    J Transl Med; 2024 Jun; 22(1):553. PubMed ID: 38858763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.
    Muto M; Baghdadi M; Maekawa R; Wada H; Seino K
    Cancer Immunol Immunother; 2015 Aug; 64(8):941-9. PubMed ID: 25904200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.